Data protection Impressum

Biotech

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (September 2025)

30 September 2025

Switzerland Innovation has launched an interactive map to simplify access to its network of innovation parks, offering international companies and partners a clearer entry point into Switzerland’s diverse R&D landscape.

Switzerland Innovation unveils new map to strengthen international visibility of its ecosystem

29 September 2025

A new automated platform developed by cellvie and CSEM streamlines mitochondria isolation, advancing therapeutic transplantation for ischemia-reperfusion injury.

CSEM and cellvie automate mitochondria isolation for clinical use

9 September 2025

Four early-stage projects from UNIL and EPFL have each secured CHF 100,000 Tech Grants from the Foundation for Innovation and Technology (FIT) to advance their technologies.

FIT awards Tech Grants to four promising start-ups from UNIL and EPFL

9 September 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (August 2025)

1 September 2025

Pilatus Biosciences launches first-in-human trial in collaboration with Roche

20 August 2025

Researchers at the University of Geneva have uncovered that astrocytes in the brain’s cortex originate from two distinct types of progenitors, a finding that could reshape therapeutic strategies for neurological disorders.

University of Geneva researchers uncover two distinct origins of key brain cells

11 August 2025

Two start-ups from Western Switzerland’s Health Valley, AzureCell Therapies and Myriad Optics, have each been awarded CHF 150,000 through the Gebert Rüf Stiftung’s Innobooster programme, which supports high-potential projects emerging from Swiss universities.

AzureCell Therapies and Myriad Optics awarded by Gebert Rüf Stiftung’s Innobooster programme

11 August 2025

Biopôle has evolved its Start Up Fund into a 24 month scheme combining non dilutive capital, investor training and growth support.

Biopôle launches enhanced Investment Programme to boost life sciences start‑ups

6 August 2025

Oculis expands its loan facility with BlackRock to CHF 100 million, extending its financial runway and supporting late-stage clinical trials.

Oculis secures up to CHF 100 million in expanded loan facility with BlackRock

5 August 2025

1 2 3 4 5 6 … 24